Energy homeostasis and body weight in obesity: new physiopathological and therapeutic considerations.
This paper reviews recent developments and findings regarding the role of the hypothalamus as the main site in the central nervous system (CNS) for regulating appetite. It contains a specific neural network consisting of the main central monoaminergic neurotransmitters (adrenaline, noradrenaline, dopamine, serotonin) and many neuropeptides with orexigenic and anorexigenic functions. The crucial relationship between CNS and obesity and the complex interconnections of CNS and peripheral peptides are becoming clearer. The mechanisms by which these hormones affect energy homeostasis through long and short-term anabolic and catabolic pathways are described. New anti-obesity therapeutic strategies based on drugs or molecules with new mechanisms of action, some not yet available in Italy but will soon be on the market, are considered.
Magnati
G
G
Department of Internal Medicine and Biomedical Science, School of Medicine, University of Parma, Italy.
Dei Cas
A
A
D001067:Appetite Depressants / Q000627:therapeutic use; D001835:Body Weight / Q000502:physiology*; D001921:Brain / Q000502:physiology; D003503:Cyclobutanes / Q000627:therapeutic use; D002149:Energy Intake; D006706:Homeostasis / Q000502:physiology*; D006801:Humans; D020738:Leptin / Q000378:metabolism; D009765:Obesity / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*
D001067:Appetite Depressants; D003503:Cyclobutanes; D020738:Leptin; C058254:sibutramine